1. Home
  2. MXCT vs EOD Comparison

MXCT vs EOD Comparison

Compare MXCT & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • EOD
  • Stock Information
  • Founded
  • MXCT 1999
  • EOD 2007
  • Country
  • MXCT United States
  • EOD United States
  • Employees
  • MXCT N/A
  • EOD N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EOD Investment Managers
  • Sector
  • MXCT Health Care
  • EOD Finance
  • Exchange
  • MXCT Nasdaq
  • EOD Nasdaq
  • Market Cap
  • MXCT 242.4M
  • EOD 235.6M
  • IPO Year
  • MXCT 2021
  • EOD N/A
  • Fundamental
  • Price
  • MXCT $2.04
  • EOD $5.50
  • Analyst Decision
  • MXCT Strong Buy
  • EOD
  • Analyst Count
  • MXCT 2
  • EOD 0
  • Target Price
  • MXCT $7.50
  • EOD N/A
  • AVG Volume (30 Days)
  • MXCT 473.0K
  • EOD 118.1K
  • Earning Date
  • MXCT 08-06-2025
  • EOD 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • EOD 9.28%
  • EPS Growth
  • MXCT N/A
  • EOD N/A
  • EPS
  • MXCT N/A
  • EOD N/A
  • Revenue
  • MXCT $37,675,000.00
  • EOD N/A
  • Revenue This Year
  • MXCT $8.36
  • EOD N/A
  • Revenue Next Year
  • MXCT $20.14
  • EOD N/A
  • P/E Ratio
  • MXCT N/A
  • EOD N/A
  • Revenue Growth
  • MXCT N/A
  • EOD N/A
  • 52 Week Low
  • MXCT $1.97
  • EOD $3.73
  • 52 Week High
  • MXCT $5.20
  • EOD $4.71
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 40.39
  • EOD 53.04
  • Support Level
  • MXCT $2.18
  • EOD $5.53
  • Resistance Level
  • MXCT $2.31
  • EOD $5.51
  • Average True Range (ATR)
  • MXCT 0.11
  • EOD 0.05
  • MACD
  • MXCT -0.01
  • EOD -0.01
  • Stochastic Oscillator
  • MXCT 18.52
  • EOD 23.85

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest

Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.

Share on Social Networks: